Cost and Prevalence of Metastatic Breast Cancer Expected to Rise Through 2030
“The results of this study highlight groups of [patients with metastatic breast cancer] by age that may require support to mitigate the adverse economic consequences from medical and productivity costs associated with the disease,” the investigators wrote.
from Google Alert - Business https://ift.tt/3wyJTOR
“The results of this study highlight groups of [patients with metastatic breast cancer] by age that may require support to mitigate the adverse economic consequences from medical and productivity costs associated with the disease,” the investigators wrote. https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/3wyJTOR
“The results of this study highlight groups of [patients with metastatic breast cancer] by age that may require support to mitigate the adverse economic consequences from medical and productivity costs associated with the disease,” the investigators wrote. https://ift.tt/eA8V8J
Comments
Post a Comment